As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ...

Pfizer ends commercialization of Beqvez hemophilia B gene therapy. CEO Kim Phelan of Coalition for Hemophilia B expresses ...

Tang Capital's Concentra Biosciences offers to buy Acelyrin for $3/share, challenging planned Alumis merger. Concentra would ...

Peter Guenter to retire as healthcare CEO, replaced by Danny Bar-Zohar; Matthias Heinzel steps down from life science unit.

Lawyers for the government gave the first substantive signal that the Trump administration will continue to defend Medicare ...

A meet­ing of CDC vac­cine ad­vi­sors has been post­poned, ac­cord­ing to a se­nior HHS of­fi­cial. “The ACIP meet­ing will ...

Has drug giant Roche finally cracked DNA sequencing? The company has claimed it can decode the genome in as little as four ...

UnitedHealthcare offers voluntary buyouts to 30,000 employees due to low attrition and digital shift, COO Michael Baker tells ...

Mother took Evrysdi for SMA before birth; baby later received Zolgensma. Dr. Richard Finkel at St. Jude led study showing no ...

The European Union’s proposed ban of so-called “forever chemicals” is expected to become law this year, and investors are ...

Charles River Labs beats Q4 estimates, Theratechnologies resumes Egrifta SV distribution, FDA greenlights BCG alternative, ...

The proxy filing for Accolade, a healthcare navigator that connects workers to care on behalf of their employers, agreed to ...